149 related articles for article (PubMed ID: 28629557)
1. Multiparametric MRI for differentiation of borderline ovarian tumors from stage I malignant epithelial ovarian tumors using multivariate logistic regression analysis.
Denewar FA; Takeuchi M; Urano M; Kamishima Y; Kawai T; Takahashi N; Takeuchi M; Kobayashi S; Honda J; Shibamoto Y
Eur J Radiol; 2017 Jun; 91():116-123. PubMed ID: 28629557
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of the MRI features in the differentiation of benign, borderline, and malignant epithelial ovarian tumors.
Xiao F; Zhang L; Yang S; Peng K; Hua T; Tang G
J Ovarian Res; 2022 Jan; 15(1):13. PubMed ID: 35062992
[TBL] [Abstract][Full Text] [Related]
3. Diffusion kurtosis imaging for differentiating borderline from malignant epithelial ovarian tumors: A correlation with Ki-67 expression.
Li HM; Zhao SH; Qiang JW; Zhang GF; Feng F; Ma FH; Li YA; Gu WY
J Magn Reson Imaging; 2017 Nov; 46(5):1499-1506. PubMed ID: 28295854
[TBL] [Abstract][Full Text] [Related]
4. Value of normalized apparent diffusion coefficients in differentiating between borderline and malignant epithelial ovarian tumors.
Lu J; Pi S; Ma FH; Zhao SH; Li HM; Cai SL; Qiang JW
Eur J Radiol; 2019 Sep; 118():44-50. PubMed ID: 31439257
[TBL] [Abstract][Full Text] [Related]
5. The serum CA-125 concentration data assists in evaluating CT imaging information when used to differentiate borderline ovarian tumor from malignant epithelial ovarian tumors.
Shin JE; Choi HJ; Kim MH; Cho KS
Korean J Radiol; 2011; 12(4):456-62. PubMed ID: 21852906
[TBL] [Abstract][Full Text] [Related]
6. Computed Tomography Indicators for Differentiating Stage 1 Borderline Ovarian Tumors from Stage I Malignant Epithelial Ovarian Tumors.
Moon MH; Park HS; Kim YJ; Yu MH; Park S; Jung SI
Diagnostics (Basel); 2023 Jan; 13(3):. PubMed ID: 36766584
[TBL] [Abstract][Full Text] [Related]
7. Diffusion-weighted MR imaging for differentiating borderline from malignant epithelial tumours of the ovary: pathological correlation.
Zhao SH; Qiang JW; Zhang GF; Ma FH; Cai SQ; Li HM; Wang L
Eur Radiol; 2014 Sep; 24(9):2292-9. PubMed ID: 24871335
[TBL] [Abstract][Full Text] [Related]
8. MRI features and score for differentiating borderline from malignant epithelial ovarian tumors.
Li YA; Qiang JW; Ma FH; Li HM; Zhao SH
Eur J Radiol; 2018 Jan; 98():136-142. PubMed ID: 29279152
[TBL] [Abstract][Full Text] [Related]
9. The enhanced T
Han X; Sun M; Wang M; Fan R; Chen D; Xie L; Liu A
Eur J Radiol; 2019 Sep; 118():187-193. PubMed ID: 31439240
[TBL] [Abstract][Full Text] [Related]
10. Texture Analysis of Three-Dimensional MRI Images May Differentiate Borderline and Malignant Epithelial Ovarian Tumors.
Ye R; Weng S; Li Y; Yan C; Chen J; Zhu Y; Wen L
Korean J Radiol; 2021 Jan; 22(1):106-117. PubMed ID: 32932563
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic efficacy of combining diffusion-weighted magnetic resonance imaging with serum Mucin 1, Mucin 13, and Mucin 16 in distinguishing borderline from malignant epithelial ovarian tumors.
Wen XT; Qiu HF; Ying LL; Huang M; Xiao YZ; Fan CC
Asia Pac J Clin Oncol; 2024 Jan; ():. PubMed ID: 38221766
[TBL] [Abstract][Full Text] [Related]
12. Application of contrast-enhanced dual-energy spectral CT for differentiating borderline from malignant epithelial ovarian tumours.
Han X; Li B; Sun M; Li J; Li Y; Liu A
Clin Radiol; 2021 Aug; 76(8):585-592. PubMed ID: 34059294
[TBL] [Abstract][Full Text] [Related]
13. Endometrioid adenocarcinoma of the ovary: MRI findings with emphasis on diffusion-weighted imaging for the differentiation of ovarian tumors.
Kovač JD; Terzić M; Mirković M; Banko B; Đikić-Rom A; Maksimović R
Acta Radiol; 2016 Jun; 57(6):758-66. PubMed ID: 26307063
[TBL] [Abstract][Full Text] [Related]
14. Diffusion-weighted MRI: a useful technique to discriminate benign versus malignant ovarian surface epithelial tumors with solid and cystic components.
Li W; Chu C; Cui Y; Zhang P; Zhu M
Abdom Imaging; 2012 Oct; 37(5):897-903. PubMed ID: 22038329
[TBL] [Abstract][Full Text] [Related]
15. Differentiation between borderline and benign ovarian tumors: combined analysis of MRI with tumor markers for large cystic masses (≥5 cm).
Park SY; Oh YT; Jung DC
Acta Radiol; 2016 May; 57(5):633-9. PubMed ID: 26231948
[TBL] [Abstract][Full Text] [Related]
16. Diffusion-weighted magnetic resonance imaging of ovarian tumors: differentiation of benign and malignant solid components of ovarian masses.
Takeuchi M; Matsuzaki K; Nishitani H
J Comput Assist Tomogr; 2010; 34(2):173-6. PubMed ID: 20351498
[TBL] [Abstract][Full Text] [Related]
17. Measurement of apparent diffusion coefficient with simultaneous MR/positron emission tomography in patients with peritoneal carcinomatosis: comparison with 18F-FDG-PET.
Schwenzer NF; Schmidt H; Gatidis S; Brendle C; Müller M; Königsrainer I; Claussen CD; Pfannenberg AC; Schraml C
J Magn Reson Imaging; 2014 Nov; 40(5):1121-8. PubMed ID: 24923481
[TBL] [Abstract][Full Text] [Related]
18. Is CA-125 an additional help to radiologic findings for differentiation borderline ovarian tumor from stage I carcinoma?
Lee EJ; Kim SH; Kim YH; Lee HJ
Acta Radiol; 2011 May; 52(4):458-62. PubMed ID: 21498310
[TBL] [Abstract][Full Text] [Related]
19. MRI appearances of ovarian serous borderline tumor: pathological correlation.
Zhao SH; Qiang JW; Zhang GF; Boyko OB; Wang SJ; Cai SQ; Wang L
J Magn Reson Imaging; 2014 Jul; 40(1):151-6. PubMed ID: 24923479
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of borderline tumors from type I ovarian epithelial cancers on CT and MR imaging.
Yang S; Tang H; Xiao F; Zhu J; Hua T; Tang G
Abdom Radiol (NY); 2020 Oct; 45(10):3230-3238. PubMed ID: 32162020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
